Crossmark

The incretin effect — almost magical

Crossref DOI link: https://doi.org/10.1038/s41574-025-01127-7

Published Online: 2025-05-07

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rasmussen, Rasmus Syberg https://orcid.org/0000-0002-5892-7859
Gasbjerg, Lærke Smidt https://orcid.org/0000-0002-7880-8515
License Information

Text and Data Mining valid from 2025-05-07

Version of Record valid from 2025-05-07
More Information

Article History

First Online: 7 May 2025

Competing interests

: R.S.R declares no competing interests. L.S.G. is a co-founder and minority shareholder of Antag Therapeutics.